Infection-associated hemophagocytic syndrome in a diabetic patient undergoing chronic hemodialysis

[1]  D. Fisman.  Hemophagocytic syndromes and infection. , 2000, Emerging infectious diseases.

[2]  K. Oizumi,et al.  [Clinical study of infection associated hemophagocytic syndrome]. , 2000, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

[3]  L. Gesualdo,et al.  Clinical relevance of cytokine production in hemodialysis. , 2000, Kidney international. Supplement.

[4]  I. Castellano,et al.  Hemophagocytic Syndrome as an Unusual Form of Presentation of Tuberculosis in a Hemodialysis Patient , 2000, American Journal of Nephrology.

[5]  T. Akizawa,et al.  Effect of plasma exchange on refractory hemophagocytic syndrome complicated with myelodysplastic syndrome. , 1999, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis.

[6]  K. Yuen,et al.  Reactive hemophagocytic syndrome associated with Penicillium marneffei infection. , 1998, The American journal of medicine.

[7]  T. Yoneyama,et al.  Interleukin-6 may mediate malnutrition in chronic hemodialysis patients. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  Yong Goo Kim,et al.  Tuberculosis-associated hemophagocytic syndrome in a hemodialysis patient: case report and review of the literature. , 1996, Nephron.

[9]  T. Akahoshi,et al.  In-vivo induction of monocyte chemotactic and activating factor in patients with chronic renal failure. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  M. Haubitz,et al.  Impaired endotoxin-induced interleukin-1 beta secretion, not total production, of mononuclear cells from ESRD patients. , 1995, Kidney international.

[11]  M. Namiki,et al.  Interleukin-8 in chronic renal failure and dialysis patients. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  M. Friedlander,et al.  Role of dialysis modality in responses of blood monocytes and peritoneal macrophages to endotoxin stimulation. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  R. Vanholder,et al.  Infectious morbidity and defects of phagocytic function in end-stage renal disease: a review. , 1993, Journal of the American Society of Nephrology : JASN.

[14]  R. Brunning,et al.  Bacteria‐associated hemophagocytic syndrome , 1984, Cancer.

[15]  V. Farewell,et al.  High incidence of neoplasia in uremic patients receiving long-term dialysis. Cancer and long-term dialysis. , 1981, Nephron.